Sjögren’s Syndrome Content
Xavier Mariette, EULAR 2021: Hot Topics in Sjögren’s Syndrome
It was great to talk with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the current challenges and potential advances in treating Sjögren’s syndrome. Questions Why have so many clinical trials failed in primary Sjögren’s syndrome? (0:15) What are the hot topics and latest research you are looking forward to exploring in Sjögren’s syndrome […]
Xavier Mariette, EULAR 2021: Belimumab plus Rituximab in Primary Sjögren’s Syndrome
It was a delight to catch up with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the phase 2 study investigating subcutaneous belimumab and intravenous rituximab in primary Sjögren’s syndrome. The abstract ‘SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!